1. Home
  2. Labeler Index
  3. Theratechnologies Inc.
  4. 62064-122
  5. NDC Package Code: 62064-122-02 Trogarzo

NDC Package 62064-122-02 Trogarzo

Ibalizumab Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62064-122-02
Package Description:
2 VIAL, SINGLE-USE in 1 CARTON / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01)
Product Code:
62064-122
Proprietary Name:
Trogarzo
Non-Proprietary Name:
Ibalizumab
Substance Name:
Ibalizumab
Usage Information:
This drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Ibalizumab-uiyk belongs to a class of drugs known as monoclonal antibodies. Ibalizumab-uiyk is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
11-Digit NDC Billing Format:
62064012202
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2043317 - ibalizumab-uiyk 200 MG in 1.33 mL Injection
  • RxCUI: 2043317 - 1.33 ML ibalizumab-uiyk 150 MG/ML Injection
  • RxCUI: 2043317 - ibalizumab-uiyk 200 MG per 1.33 ML Injection
  • RxCUI: 2043322 - TROGARZO 200 MG in 1.33 mL Injection
  • RxCUI: 2043322 - 1.33 ML ibalizumab-uiyk 150 MG/ML Injection [Trogarzo]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Theratechnologies Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • IBALIZUMAB 150 mg/mL
    • Pharmacologic Class(es):
  • Antibodies, Monoclonal, Humanized - [CS]
  • CD4-directed Antibody Interactions - [MoA] (Mechanism of Action)
  • CD4-directed Blocking Antibody - [EPC] (Established Pharmacologic Class)
  • HIV 1 Post-attachment Fusion Inhibitors - [MoA] (Mechanism of Action)
  • Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA761065
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-20-2018
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 62064-122-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    62064012202J1746Inj., ibalizumab-uiyk, 10 mg10 MG1.3322040

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 62064-122-02?

    The NDC Packaged Code 62064-122-02 is assigned to a package of 2 vial, single-use in 1 carton / 1.33 ml in 1 vial, single-use (62064-122-01) of Trogarzo, a human prescription drug labeled by Theratechnologies Inc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 62064-122 included in the NDC Directory?

    Yes, Trogarzo with product code 62064-122 is active and included in the NDC Directory. The product was first marketed by Theratechnologies Inc. on April 20, 2018 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 62064-122-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 62064-122-02?

    The 11-digit format is 62064012202. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-262064-122-025-4-262064-0122-02